Twin Strand Biosciences specializes in advanced genomic sequencing technologies.Since traditional sequencing methods can be prone to errors, TwinStrand developed Duplex Sequencing, which individually labels and tracks complementary strands of DNA. This allows the comparison of the complimentary strands, significantly reducing sequencing errors, and allowing researchers to detect rare genetic mutations and low-frequency variants with unprecedented sensitivity. This Duplex Sequencing method is said to have 10,000-fold higher accuracy compared to standard next-gen sequencing. Their proprietary software allows for easy interpretation of sequencing data. TwinStrand’s technology is instrumental in uncovering the underlying genetic drivers of diseases and identifying potential therapeutic targets.

TwinStrand Biosciences

Founded: 2016
Location: Seattle, WA
Employee range: 50 - 200
Funding: $10M Jul 2023; $50M May 2021; $16M A Jan 2020

Short description:

Drug notes:

Long description:

Jobs: